PEOPLE - Changes at the NHS:
This article was originally published in Clinica
The UK National Health Service (NHS) has announced the members of its prostate brachytherapy advisory group. Ms Niki Bartrop (NHS commissioning advisor, Woking); Dr David Bottomley (consultant clinical oncologist, Cookeridge Hospital, Leeds); Professor Stephen Langley (chairman of the group - Professor of urology, St Luke's Cancer Centre, Guildford); Mr Richard Gledhill (prostate cancer charity specialist nurse, Queen Elizabeth Hospital, Birmingham); and Mr Richard Popert (consultant urological surgeon, Guy's and St Thomas' NHS Trust, London). The group has been formed to develop and improve the delivery of brachytherapy services in the UK.
You may also be interested in...
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.